WallStreetZenWallStreetZen

NASDAQ: KMDA
Kamada Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Kamada earnings were $19.0M for the trailing 12 months ending Jun 30, 2025, with 17.9% growth year over year. The latest KMDA earnings report on Jun 30, 2025 announced Q2 2025 earnings of $7.4M, up 86.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, KMDA reported annual earnings of $14.5M, with 74.6% growth. The next KMDA earnings date is Nov 12, 2025.

KMDA past earnings growth

How has KMDA's earnings growth performed historically?

Company
17.86%
Industry
28.88%
Market
34.44%
KMDA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
KMDA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
KMDA's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

KMDA earnings history

Current Revenue
$169.5M
Current Earnings
$19.0M
Current Profit Margin
11.2%

KMDA Return on Equity

Current Company
7.4%
Current Industry
18%
Current Market
30.7%
KMDA's Return on Equity (7.4%)... subscribe to Premium to read more.
High Return on Equity Performance

KMDA undefined

Current Company
5.2%
Current Industry
7%
KMDA is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when KMDA announces earnings.

KMDA undefined

Current Company
6.05%
Current Industry
13.9%
KMDA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

KMDA vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
KMDA$34.21M$19.01M-7.60%$0.33
EOLS-$33.58M-$62.00MN/A-$0.97
EBS$105.40M-$131.60MN/A-$2.54
ETON-$273.00k-$4.58MN/A-$0.19
LFCR-$14.23M-$49.40MN/A-$1.48
View Top Pharmaceutical Stocks

KMDA earnings dates

Next earnings date
Nov 12, 2025

Kamada Earnings Reports & History FAQ

What were Kamada's earnings last quarter?

On KMDA's earnings call on Invalid Date, Kamada (NASDAQ: KMDA) reported Q2 2025 earnings per share (EPS) of $0.13, up 62.5% year over year. Total KMDA earnings for the quarter were $7.38 million. In the same quarter last year, Kamada's earnings per share (EPS) was $0.08.

If you're new to stock investing, here's how to buy Kamada stock.

When does Kamada report earnings?

The next KMDA earnings date is Invalid Date. Add KMDA to your watchlist to be reminded of Kamada's next earnings date.

Is Kamada profitable or losing money?

As of the last Kamada earnings report, Kamada is currently profitable. Kamada's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $19.01 million, a 26.13% increase year over year.

What was KMDA's earnings growth in the past year?

As of Kamada's earnings date in Invalid Date, Kamada's earnings has grown 17.86% year over year. This is 11.02 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 28.88%. KMDA earnings in the past year totalled $19.01 million.

What are Kamada's earnings expectations?

The current EPS estimate for Kamada's earnings report in Invalid Date is $0.09.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.